Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies - Clinical response to excision of the primary tumor

被引:53
作者
de la Sayette, V [1 ]
Bertran, F
Honnorat, J
Schaeffer, S
Iglesias, S
Defer, G
机构
[1] CHU Cote de Narce, Neurol Serv, Dept Neurol, F-14033 Caen, France
[2] Hop Neurol, Dept Neurol, INSERM, U433, Lyon, France
关键词
D O I
10.1001/archneur.55.3.405
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To describe a patient with a paraneoplastic cerebellar syndrome and optic neuritis with circulating anti-CV2 antibodies and clinical improvement after excision of a small cell lung carcinoma. Design: Report of a case. Setting: A 62-year-old man simultaneously developed a severe cerebellar syndrome and a bilateral optic neuritis predominantly in the left eye (visual acuity, 20/25 in the right eye; <20/400 in the left eye; and bilateral swelling of the optic discs). Main Outcome and Results: Anti-CV2 antibodies, recently described as associated with paraneoplastic neurological syndrome, were detected in the patient's serum sample. These antibodies were demonstrated to react with the cytoplasm of a subpopulation of oligodendrocytes in the white matter of rat brain in the cerebellum, brainstem, spinal cord, and optic chiasm. The patient was found to have a small cell lung carcinoma, which was removed. After excision of the tumor, the cerebellar syndrome improved dramatically and the papilledema disappeared despite aftereffects of the optic neuritis. Conclusions: These findings were consistent with the diagnosis of a paraneoplastic neurological syndrome, although both optic neuritis and remission of the cerebellar syndrome are uncommon patterns of paraneoplastic syndromes. CV2 antigen expression by the oligodendrocytes of the cerebellum, brainstem, spinal cord, and optic chiasm correlated with the clinical syndrome observed in our patient. However, the precise pathophysiological role of anti-CV2 antibodies is still unknown.
引用
收藏
页码:405 / 408
页数:4
相关论文
共 27 条
[11]  
2-9
[12]  
HENSON RA, 1982, CANCER NERVOUS SYSTE, P311
[13]   Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes [J].
Honnorat, J ;
Antoine, JC ;
Derrington, E ;
Aguera, M ;
Belin, MF .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (03) :270-278
[14]   A CLINICAL TRIAD TO DIAGNOSE PARANEOPLASTIC RETINOPATHY [J].
JACOBSON, DM ;
THIRKILL, CE ;
TIPPING, SJ .
ANNALS OF NEUROLOGY, 1990, 28 (02) :162-167
[15]   PARA-NEOPLASTIC CEREBELLAR DISEASE - REMISSION WITH EXCISION OF THE PRIMARY TUMOR [J].
KEARSLEY, JH ;
JOHNSON, P ;
HALMAGYI, GM .
ARCHIVES OF NEUROLOGY, 1985, 42 (12) :1208-1210
[16]   PHOTORECEPTOR DEGENERATION - POSSIBLE AUTOIMMUNE DISORDER [J].
KELTNER, JL ;
ROTH, AM ;
CHANG, RS .
ARCHIVES OF OPHTHALMOLOGY, 1983, 101 (04) :564-569
[17]   Unusual expression of the HU paraneoplastic antigen in the visual system [J].
Kostyk, SK ;
Wheeler, EL ;
Wagner, JA .
NEUROREPORT, 1996, 7 (10) :1549-1552
[18]  
MALIK S, 1992, J CLIN NEURO-OPHTHAL, V12, P137
[19]   EARLY DIAGNOSIS AND INTRAVENOUS IMMUNE GLOBULIN THERAPY IN PARANEOPLASTIC CEREBELLAR DEGENERATION [J].
MOLL, JWB ;
HENZENLOGMANS, SC ;
VANDERMECHE, FGA ;
VECHT, CJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (01) :112-112
[20]   GUIDELINES ON THE DETECTION OF PARANEOPLASTIC ANTI-NEURONAL-SPECIFIC ANTIBODIES - REPORT FROM THE WORKSHOP TO THE 4TH MEETING OF THE INTERNATIONAL-SOCIETY-OF-NEURO-IMMUNOLOGY ON PARANEOPLASTIC NEUROLOGICAL DISEASE, HELD OCTOBER 22-23, 1994, IN ROTTERDAM, THE NETHERLANDS [J].
MOLL, JWB ;
ANTOINE, JC ;
BRASHEAR, HR ;
DELATTRE, J ;
DRLICEK, M ;
DROPCHO, EJ ;
GIOMETTO, B ;
GRAUS, F ;
GREENLEE, J ;
HONNORAT, J ;
JAECKLE, KA ;
TANAKA, K ;
VECHT, CJ .
NEUROLOGY, 1995, 45 (10) :1937-1941